Source comparison
BPC-157 Gut Health Protocol: Method Comparison
Subcutaneous injection 90-95% systemic absorption; peptide reaches gut tissue via circulation Twice daily (morning/evening) for sustained plasma levels Indirect. Relies on systemic circulation and inflammatory chemotaxis to damaged mucosa Gold standard for con
This comparison does not assign a generated winner or score.
- Subcutaneous injection
- 90-95% systemic absorption; peptide reaches gut tissue via circulation
- Twice daily (morning/evening) for sustained plasma levels
- Indirect. Relies on systemic circulation and inflammatory chemotaxis to damaged mucosa
- Gold standard for consistent plasma levels; requires sterile technique and proper reconstitution but delivers predictable tissue exposure
- Oral capsules (enteric-coated)
- <10% due to gastric acid and enzymatic degradation; unstable peptide structure
- Once daily, typically before bed
- Direct mucosal contact in small intestine if coating survives gastric transit
- Theoretically beneficial for localised gut contact, but degradation rates make dosing unreliable; clinical evidence is minimal compared to injectable forms
- Intramuscular injection
- 85-90% systemic; faster initial peak than subcutaneous but shorter duration
- Once daily due to depot effect in muscle tissue
- Indirect via systemic circulation
- Viable alternative if subcutaneous sites are exhausted, but higher risk of injection site soreness and no proven advantage over subcutaneous for gut applications